Cargando…

The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature

The Edwards SAPIEN™ transcatheter heart valve (Edwards Lifesciences LLC, Irvine, CA, USA) is approved by the US Food and drug administration for use in the aortic position in patients with severe aortic stenosis who are not surgical candidates. This approval was backed by data from the Placement of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holoshitz, Noa, Kavinsky, Clifford J., Hijazi, Ziyad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107442/ https://www.ncbi.nlm.nih.gov/pubmed/25135160 http://dx.doi.org/10.1007/s40119-012-0006-8

Ejemplares similares

Transcatheter Aortic and Mitral Valve‐in‐Valve Implantation Using the Edwards Sapien 3 Heart Valve
por: Shivaraju, Anupama, et al.
Publicado: (2018)

Larger Valve Size is Associated with Permanent Pacemaker Implantation in Edwards SAPIEN 3™ Transcatheter Aortic Valves
por: Ahmad, Mansoor, et al.
Publicado: (2019)

Prevalence and Significance of Patient Prosthesis Mismatch Following Edwards SAPIEN XT and SAPIEN 3 Transcatheter Aortic Valve Replacement
por: Vallabhaneni, Srilakshmi, et al.
Publicado: (2021)

Comparing the Procedural and Clinical Outcomes of Sapien XT and Sapien 3 Valves in Transcatheter Aortic Valve Replacement in Korean Patients
por: Kook, Hyungdon, et al.
Publicado: (2020)

Noninvasive pacing during transfemoral implantation of the Edwards SAPIEN valve for tricuspid valve bioprosthesis stenosis
por: Demkow, Marcin, et al.
Publicado: (2016)

Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis—Impact of Valve Size in a Single Center Experience
por: Wöhrle, Jochen, et al.
Publicado: (2016)

Pediatric tricuspid valve replacement with a transcatheter aortic valve (SAPIEN 3)
por: Kalangos, Afksendiyos, et al.
Publicado: (2020)

Concomitant use of Sapien 3 transcatheter valve for severe MAC with Intuity Elite rapid deployment valve for aortic stenosis
por: Hooks, Gareth J., et al.
Publicado: (2022)

Percutaneous mitral valve repair: The MitraClip device
por: Suradi, Hussam S., et al.
Publicado: (2016)

Spotlight on the SAPIEN 3 transcatheter heart valve
por: Rheude, Tobias, et al.
Publicado: (2018)

Routine Predeployment Balloon Aortic Valvuloplasty During Transcatheter Aortic Valve Replacement: Time to Move On?
por: Poulin, Marie‐France, et al.
Publicado: (2017)

Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
por: Kralisz, Paweł, et al.
Publicado: (2021)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

Undeliverable Sapien 3 prosthesis in transaortic transcatheter aortic valve implantation
por: Shirasaka, Tomonori, et al.
Publicado: (2021)

Transcatheter heart valve in valve implantation with Edwards SAPIEN bioprosthetic valve for different degenerated bioprosthetic valve positions (First Iranian ViV report with mid-term follow up)
por: Haji Zeinali, Ali Mohammad, et al.
Publicado: (2017)

Transcatheter Aortic Valve Therapy for Bicuspid Aortic Valve Stenosis
por: Dayawansa, Nalin H., et al.
Publicado: (2023)

Conduction disorders after transcatheter aortic valve implantation: A comparison between SAPIEN 3 and SAPIEN 3 Ultra balloon-expandable valves
por: Monizzi, Giovanni, et al.
Publicado: (2022)

Transcatheter Pulmonary Valve Replacement
por: Ghawi, Hani, et al.
Publicado: (2012)

The first clinical data of the SAPIEN 3 aortic valve in the treatment of aortic stenosis in China
por: Shang, Xiaoke, et al.
Publicado: (2023)

Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk
por: Kuck, Karl H., et al.
Publicado: (2023)

Prosthetic Valve Function after Aortic Valve Replacement for Severe Aortic Stenosis by Transcatheter Procedure versus Surgery
por: Saito, Shunsuke, et al.
Publicado: (2022)

Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIEN™ 3 TAVR Valves: A Single-Center Experience
por: Ahmad, Mansoor, et al.
Publicado: (2019)

Extensive calcification of the mitral valve annulus in transcatheter aortic valve implants
por: Haensig, Martin, et al.
Publicado: (2021)

Transcatheter aortic valve replacement with Lotus and Sapien 3 prosthetic valves: a systematic review and meta-analysis
por: Gozdek, Mirosław, et al.
Publicado: (2020)

CoreValve vs. Sapien 3 Transcatheter Aortic Valve Replacement: A Finite Element Analysis Study
por: Nappi, Francesco, et al.
Publicado: (2021)

Unique challenges posed by a dysfunctional native right ventricular outflow tract for percutaneous pulmonary valve implantation using SAPIEN-S3 valve
por: Sivakumar, Kothandam, et al.
Publicado: (2022)

Sex-specific aortic valve calcifications in patients undergoing transcatheter aortic valve implantation
por: Hokken, Thijmen W, et al.
Publicado: (2023)

The effect of X‐ray beam distortion on the Edwards Sapien XT (™) trans‐catheter aortic valve replacement prosthesis
por: Crowhurst, James A., et al.
Publicado: (2015)

Unequal quadricuspid aortic valve stenosis treated with transcatheter aortic valve replacement
por: Fukui, Tomoki, et al.
Publicado: (2020)

Supraclavicular Subclavian access for Sapien Transcatheter aortic valve replacement- a novel approach
por: Dahle, Thom G., et al.
Publicado: (2018)

Leadless Pacemaker Implantation Following Transcatheter Aortic Valve Implantation Using SAPIEN 3
por: Shikama, Taku, et al.
Publicado: (2018)

Commentary: Suppressing the inflammatory response—can it be an alternative to surgical aortic valve replacement and transcatheter aortic valve replacement for patients with calcific aortic stenosis?
por: Lazar, Harold L.
Publicado: (2020)

Cerebral Ischemic Lesions after Transcatheter Aortic Valve Implantation in Patients with Non-Calcific Aortic Stenosis
por: Liu, Xianbao, et al.
Publicado: (2022)

Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience
por: Sawaya, Fadi J, et al.
Publicado: (2016)

Rationale and design of the Edwards SAPIEN-3 periprosthetic leakage evaluation versus Medtronic CoreValve in transfemoral aortic valve implantation (ELECT) trial: A randomised comparison of balloon-expandable versus self-expanding transcatheter aortic valve prostheses
por: Abawi, M., et al.
Publicado: (2016)

Hemodynamic Performance of Two Current-Generation Transcatheter Heart Valve Prostheses in Severely Calcified Aortic Valve Stenosis
por: Potratz, Max, et al.
Publicado: (2022)

Concomitant Redo Transcatheter Aortic Valve Replacement and Valve-in-Mitral Annular Calcification
por: Nagaraja, Vinayak, et al.
Publicado: (2022)

Conduction Disturbance, Pacemaker Rates, and Hospital Length of Stay Following Transcatheter Aortic Valve Implantation with the Sapien 3 Valve
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Aortic valve stenosis after previous coronary bypass: Transcatheter valve implantation or aortic valve replacement?
por: Jegaden, Olivier, et al.
Publicado: (2012)

Aortic Valve Calcification as a Predictor of Post-Transcatheter Aortic Valve Replacement Pacemaker Dependence
por: Sharma, Esseim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4a9v2ismeflt6kf95htmgo8g7e